エピソード

  • Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

    Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics
    2021/05/07
    In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration. Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year. Also, an update from our underground medtech analyst – Barry the Groundhog. Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify
    続きを読む 一部表示
    48 分
  • Ep 56 - Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?

    Ep 56 - Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?
    2021/04/30
    Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices. In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world. Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company. She also shares how the technology ultimately restored the life of someone very close to her. Chris Newmarker, executive editor of MassDevice, offers up his Top 5 Newmarker’s Newsmakers including news about human-monkey embryos, Abbott, Stryker, Medtronic and DJO. Don't forget to subscribe to this podcast! And our new MedtronicTalks podcast.
    続きを読む 一部表示
    1 時間 4 分
  • Ep 55 - CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family

    Ep 55 - CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family
    2021/04/23
    In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the Medtech industry. • The potential for its ZIO cardiac monitoring technology • How the company is dealing with a disappointing reimbursement • How the company will pursue the large asymptomatic market • What’s expected to come from the company’s partnership with Verily We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes. Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjnewmakers bringing news from Zimmer Biomet, Stryker, Emergent Biosolutions, Intuitive Surgical, Medtronic and NeuroPace. Subscribe on all major podcast players.
    続きを読む 一部表示
    58 分
  • Ep 54 - How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

    Ep 54 - How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?
    2021/04/16
    This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.
    続きを読む 一部表示
    56 分
  • Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

    Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey
    2021/04/09
    In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so well in medtech and how the medical device industry would benefit from including more veterans in its workforce. We’ll also hear from Kwame Ulmer, principal at Ulmer Ventures and a lecturer at UCLA Anderson’s School of Management, about an effort his helping to lead to update the landmark study compiled by Josh Makower in 2010. The study blasted a regulatory process that it called “unpredictable, inefficient and expensive.” Its finding led to introspection and changes, according to Ulmer who served at the FDA at the time. Now Ulmer is working with UCLA leaders to update the study. He’s hoping to connect with 200 medical device and digital health executives to understand how they’re working with the agency. For more information go to MedtechStudy.com. For more information on the original study go here - https://www.massdevice.com/study-fda-related-activities-cost-24-million-510k/ Meanwhile, Medtech Media Mogul Chris Newmarker, executive editor of life sciences, will unveil his Newmarker’s Newsmakers including reports from Google, Varian, Boston Scientific, Hologic, LumiraDx, and a report detailing racial inequity in how LVADs are implanted. Subscribe to this podcast on all major podcast applications.
    続きを読む 一部表示
    1 時間 13 分
  • Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

    Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology
    2021/04/02
    This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail. First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision. Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal. And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott. Finally, don’t forget to join us on Clubhouse for DeviceTalks Weekly Live at 1 pm ET on Wed.
    続きを読む 一部表示
    1 時間 5 分
  • Ep 51 - CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids

    Ep 51 - CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids
    2021/03/26
    Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity. In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world. He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health. While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases. CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry. We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology. Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker's Newsmakers including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic. Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device are faring a year after the start of the pandemic. https://www.medicaldesignandoutsourcing.com/how-big-medtech-fared-during-a-year-of-covid-19/ Subscribe now on all major podcast channels.
    続きを読む 一部表示
    1 時間 17 分
  • Ep 50 - J&J’s McEvoy talks vaccines, digital surgery, and the power of innovation; Stryker’s Murray sees 3D

    Ep 50 - J&J’s McEvoy talks vaccines, digital surgery, and the power of innovation; Stryker’s Murray sees 3D
    2021/03/19
    HAPPY BIG 5-0!! This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate! Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut. In this update, McEvoy delivers great insights on several areas of interest including: • COVID-19’s impact on J&J in the past, and what changes may remain in the future. • J&J’s far-ranging digital surgery portfolio could bolster many of its specialties. • How the company uses its innovation network to accelerate development • Why she’s bullish on the future of eye care. • How the company will prepare for future challenges. We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader. She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com. Colleague Lisa Eitel, executive editor of Design World, crashes the party to tell us about her upcoming Women in Engineering webcast. Register for that discussion at https://www.designworldonline.com/design-world-online-events-and-webinars/ Finally, Chris Newmarker delivers some good news and bad Newmarker's Newsmakers from the digital pages of MassDevice, Medical Design & Outsourcing, and other sites. Companies highlighted include Frequency, Medtronic, Theranos, GE Healthcare, DJO and Stryker Subscribe now on any major podcast channel. Google. Apple. Spotify. Amazon, etc.
    続きを読む 一部表示
    1 時間 15 分